&w=3840&q=100)
The Good Bug raises ₹100 crore to scale gut health R&D and reach
Gut health-focused start-up The Good Bug (TGB) has raised ₹100 crore in a new funding round led by Susquehanna Asia VC, with participation from existing investor Fireside Ventures. The capital will be used to expand the company's research and development capabilities, strengthen marketing and distribution, and hire talent across research, technology and business functions.
Founded in 2022 by Keshav Biyani and Prabhu Karthikeyan, TGB offers a range of synbiotics, probiotics, prebiotics, detox products, and fermented items such as kombucha and kefir. Its products are positioned to address issues related to digestion, obesity and women's wellness, using microbiome and gut bacterial science.
This is the largest funding round for the company to date, following a $4 million (₹35 crore) Series A extension round in 2024 led by Sharrp Ventures, the family office of Marico Group Chairman Harsh Mariwala. Fireside Ventures led the company's original Series A round in 2023.
TGB claims over one million customers across India and has recently launched a new product in the weight management segment — the 'Advanced Metabolic System' — which the company says uses natural ingredients to elevate GLP-1 levels and reduce chronic gut inflammation.
Keshav Biyani, Co-founder of The Good Bug, said the funding will help scale the firm's R&D efforts and increase consumer reach.
Bhavani Rana, Investment Advisor to Susquehanna Asia VC, said the firm sees potential in TGB's microbiome-based approach to digestive health and cited India's growing nutraceuticals market as a key growth driver.
Fireside Ventures Principal Ankur Khaitan said the investor remains committed to the company's long-term strategy.
TGB's latest round comes amid rising global interest in microbiome science and a broader consumer shift towards preventive health solutions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
32 minutes ago
- Time of India
Attention B2C GST filers who are facing problem with GSTR-1: GSTN issues new advisory, Here's what experts say
The Goods and Service Tax Network ( GSTN ) has issued an advisory tweet mentioning that in table 12 of GSTR-1 return, B2B supplies information is mandatory, but B2C is optional. This means those Goods and Services Tax (GST) registered taxpayers who have to file GSTR-1 return on or before June 11, 2025 for June 2025 tax period need to mandatorily give their B2B sales information and HSN code , otherwise the system won't allow filing it. However, this has created another problem namely for those GST registered taxpayers who are selling their services or products to end consumers i.e. those with only B2C sales and no B2B sales. What did GSTN say about this problem? In a tweet dated June 7, 2025, GSTN said: As per the current implemented design, the GST system is only validating the values in Table -12 of GSTR-1 concerning the B2B table which is mandatory. Whereas the GST system is allowing any numerical value to be entered in B2C table of Table-12 of GSTR-1, even it could be left empty as the said field is not mandatory.' Chartered Accountant Deep Koradia says: 'GSTN has changed the GSTR-1 form and now separate reporting for B2B supply and B2C Supply. It's mandatory to report GSTR-1 B2B supply invoice details and its corresponding HSN codes from the May 2025 tax period. B2C supply details are optional for now. But the problem is for those GST registered taxpayers who don't have any B2B supplies. The system is not letting these taxpayers file their GSTR-1 return as their B2B supply HSN code column is blank, the deadline for which is June 11, 2025.' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villa For Sale in Dubai Might Surprise You Villas in Dubai | Search ads Learn More Undo The image below shows how GSTR-1 filers can't file GSTR-1 due to absence of B2B sales. GSTR-1 Source: CA Deep Koradia Live Events — Infosys_GSTN (@Infosys_GSTN) Buyers GST input tax credit may be delayed if sellers can't file GSTR-1 on time Koradia explains: 'Ideally GSTN should make both B2C and B2B supply reporting mandatory ONLY IF there is such supply in their respective tab, but instead of solving this problem, GSTN issued a clarification that B2B is mandatory, and B2C is optional. As a direct impact of sellers being unable to file their GSTR-1 return, buyers will not be able to claim their input tax credit for May 2025 tax period as their GSTR-3B will not get auto-populated with this detail. The reason for this is that the seller's GSTR-1 return feeds information into the buyer's GSTR-3B.' What is the solution to this problem? Koradia says: 'Till the time GSTN comes out with a solution for this problem, we have found a makeshift solution. Sellers with no B2B sales should write 0 (zero) in the HSN column of B2B and then fill up the B2C data. This will enable them to file GSTR-1 returns successfully.' What is table 12 of GSTR-1 return? In an advisory GSTN said: In Table-12 validation with regards to value of the supplies have also been introduced. These validations will validate the value of B2B supplies shown in different Tables viz: 4A, 4B, 6B, 6C, 8 (recipient registered), 9A, 9B (registered), 9C (registered), 15 (recipient registered), 15A (recipient registered) with the value of B2B supplies shown in table-12) Similarly, validations will validate the value of B2C supplies shown in different tablesviz: 5A, 6A, 7A, 7B, 8 (recipient unregistered), 9A (export), 9A (B2CL), 9B(unregistered), 9C (unregistered), 10, 15 (recipient unregistered), 15A (recipientunregistered) with the value of B2C supplies shown in Table-12. In case of amendments, only the differential value will be taken for the purpose of validation.
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
EB-5 visa gains popularity as Indians face H-1B and F-1 challenges
The EB-5 visa program is fast emerging as a preferred route for individuals looking to migrate to the United States (US). In the first quarter of calendar year 2025 (CY25), a total of 4,608 EB-5 visas were granted globally, marking a 90 per cent year-on-year (Y-o-Y) increase. Nicholas Mastroianni III, president and chief marketing officer of the US Immigration Fund (USIF) — one of the leading EB-5 regional center operators — said demand from Indians has risen, both among those residing in India and those already in the US on H-1B and F-1 visas. 'There's a clear uptick in interest. We've seen more inquiries from people still in India, and also from parents of students on F-1 visas. The current uncertainty around H-1B and F-1 statuses in the US is prompting families to explore EB-5 as a more secure route,' Mastroianni told Business Standard during his visit to Mumbai. The trend is reflected in the numbers. As of year-to-date (YTD) 2025, Indian nationals had filed 649 EB-5 visa petitions under consular processing. When combined with adjustment of status (AOS) applications — filed by those already in the US — the total is expected to surpass 2024's figure of 733 petitions. EB-5 visa program has been around for 30 years now, but has been underutilised, according to Mastroianni. For USIF, India is its second-largest market, after China. As a route for immigration, EB-5 program also has a cap of issuing 10,000 visas annually. The program also has a 7 per cent cap per country to ensure fair distribution of visas. An individual opting for this route has to pay a fee of $800,000. Since 2016, USIF has facilitated the migration of 200-250 Indian families. 'Just since January, we've seen nearly 50 families from India move ahead with the EB-5 process,' Mastroianni said. Significant reforms in 2020 included a 40 per cent fee hike and stricter compliance, which briefly slowed investor interest. Currency restrictions and broader global uncertainty also contributed. However, 2025 has brought a resurgence in demand, said Mastroianni. However, he added that since the beginning of this year, EB-5 as a category has seen a significant pickup. 'One of the reasons is the clarity, so anyone who files a petition under EB-5 now will be grandfathered under the EB-5 reforms until September 30, 2026,' he said. This basically means that even if the program gets modified or changed, the petitions filed will continue to be processed. When asked about the proposed 'Golden Visa' or 'Gold Card' for the US, Mastroianni said the EB-5 and Gold Card could coexist. 'The Gold Card still needs approval by both Congress and the Senate. Proposals like exempting participants from taxes would require changes to IRS codes — that's no small feat,' he said. Moreover, whenever the Gold Card becomes a reality, it will focus on wealth-based migration, whereas EB-5 brings investors to the US. The EB-5 route allows individuals to become investors. 'The USIF is a fund, we have more than 25 funds that pool or bring investors together and finance projects in the US. These investments have to create jobs. Several political leaders in the current US government are aware of the EB-5 impact. Rather many of the members' real estate projects have seen investment from EB-5 petitioners, hence they are aware the kind of jobs that have been created in the US,' he said. With the uncertainty over visa only increasing, USIF also launched another program called the 'Opportunity Fund Lender'. 'Investors across the world or even those in the US can invest through EB-5 with $400,000. They can finance up to 50 per cent of the rest of the investment, depending on their qualification,' said Mastroianni.
India.com
3 hours ago
- India.com
COVID 19 Cases in India: Active Cases Jump To 6491
COVID 19 Cases Rising In India Live Updates: India is once again witnessing an unsettling rise in COVID-19 cases, with the number of active infections climbing to 6491; according to the Ministry of Health and Family Welfare's latest update as of 12:00 AM IST, June 9, 2025. As per May 2025 classifications by the World Health Organization (WHO), subvariants LF.7 and NB.1.8.1 are categorized as Variants Under Monitoring, meaning they are not yet deemed as Variants of Concern or Variants of Interest. However, these strains are suspected to be contributing to the rising infections not just in India but also across China and other parts of Asia. Despite the emergence of new subvariants, the JN.1 strain remains the most dominant, accounting for a staggering 53% of all positive cases across the country. According to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a case of NB.1.8.1 was detected in Tamil Nadu in April, while four cases of LF.7 were identified in Gujarat earlier this month. With the virus subtly shifting form and symptoms evolving, health authorities are urging the public to maintain precautionary measures, including hygiene, mask use in crowded places, and timely testing. Although hospitalisation remains low, experts warn that complacency could reverse progress. Stay informed, and if you're experiencing mild symptoms like fatigue, a sore throat, or gastrointestinal discomfort, it's best to test early and isolate to prevent further spread.
